Daan Nevens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daan Nevens has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
S. Nuyts
6 shared publications- Sandra Nuyts
Department of Radiation Oncology, Leuven Cancer Institute University Hospitals Leuven Leuven Belgium
4 shared publications F. Duprez
Department of Radiotherapy, Ghent University Hospital, 9000, Ghent, Belgium
3 shared publicationsM. Lambrecht
3 shared publicationsW. De Neve
Department of Radiotherapy, Ghent University Hospital, 9000, Ghent, Belgium
3 shared publications- Eddy Dejaeger
UZ Leuven - University Hospitals Leuven, Department of Geriatrics, UZ Leuven campus Pellenberg, Weligerveld 1, 3212 Pellenberg, Belgium
2 shared publications
Latest Publications
- 23 May 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1088) , 20180155
Clinical factors impacting on late dysphagia following radiotherapy in patients with head and neck cancer
Objective:Patient and treatment characteristics of patients with head and neck cancer (HNSCC) were correlated with dysphagia scored on swallowing-videofluoroscopy (VFS) and with patient and physician scored dysphagia.Methods:Sixty-three HNSCC patients treated with radiotherapy (RT) were evaluated at baseline, 6 and 12 months post-RT. VFS was scored with Penetration Aspiration Scale (PAS) and Swallowing Performance Scale (SPS). Physician and patient scored dysphagia were prospectively recorded according to CTCAE scoring system, RTOG/EORTC scoring system and EORTC-QLQ H&N35 questionnaire.Results:Univariable analysis revealed a significant association between tumour-subsite and higher SPS (p = 0.02) and patient scored dysphagia (p = 0.02) at baseline. At 12 months, tumour-subsite was significantly associated with higher PAS and SPS. Multivariable analysis and pairwise comparison showed that hypopharyngeal cancer and carcinoma of unknown primary (CUP) were associated with higher SPS at baseline and at 12 mont...
- 23 May 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1088) , 20180155
Clinical factors impacting on late dysphagia following radiotherapy in patients with head and neck cancer
Objective:Patient and treatment characteristics of patients with head and neck cancer (HNSCC) were correlated with dysphagia scored on swallowing-videofluoroscopy (VFS) and with patient and physician scored dysphagia.Methods:Sixty-three HNSCC patients treated with radiotherapy (RT) were evaluated at baseline, 6 and 12 months post-RT. VFS was scored with Penetration Aspiration Scale (PAS) and Swallowing Performance Scale (SPS). Physician and patient scored dysphagia were prospectively recorded according to CTCAE scoring system, RTOG/EORTC scoring system and EORTC-QLQ H&N35 questionnaire.Results:Univariable analysis revealed a significant association between tumour-subsite and higher SPS (p = 0.02) and patient scored dysphagia (p = 0.02) at baseline. At 12 months, tumour-subsite was significantly associated with higher PAS and SPS. Multivariable analysis and pairwise comparison showed that hypopharyngeal cancer and carcinoma of unknown primary (CUP) were associated with higher SPS at baseline and at 12 mont...
- 3 March 2018
- Published by Springer Nature in Dysphagia
- Vol. 33 (5) , 684-690
Correlation of Patient- and Physician-Scored Dysphagia with Videofluoroscopies in Patients Treated with Radiotherapy for Head and Neck Cancer
The aim of this study was to investigate the correlation between patient-scored dysphagia and physician-scored dysphagia in head and neck cancer patients treated with radiotherapy. Furthermore, we wanted to compare both patient- and physician-scored dysphagia with dysphagia evaluated on swallowing videofluoroscopies. Sixty-three patients from two different centers treated with radiotherapy for head and neck cancer were evaluated in the current study. Swallowing videofluoroscopies at baseline, 6, and 12 months following radiotherapy were evaluated by 2 observers using the Penetration Aspiration Scale (PAS) and Swallowing Performance Status Scale (SPS) and correlated with patient and physician scored dysphagia. We observed a significant association between physician and patient scored dysphagia (p < 0.01), pre-treatment and post-treatment. Furthermore, the risk of observing dysphagia on videofluoroscopies increased significantly with increasing scores of both physician as well as patient scored dysphagia, and this at all assessed time-points. Patient-scored dysphagia correlates better with dysphagia evaluated by the PAS. Physician-scored dysphagia, however, correlates better with dysphagia as evaluated using the SPS. Both physician- and patient-scored dysphagia correlate well with dysphagia evaluated on videofluoroscopies. Since patient-scored dysphagia correlates better with PAS and changes in the PAS score, and physician-scored dysphagia correlates better with SPS, we advocate to use both patient- and physician-scored dysphagia in future trials.
- 3 March 2018
- Published by Springer Nature in Dysphagia
- Vol. 33 (5) , 684-690
Correlation of Patient- and Physician-Scored Dysphagia with Videofluoroscopies in Patients Treated with Radiotherapy for Head and Neck Cancer
The aim of this study was to investigate the correlation between patient-scored dysphagia and physician-scored dysphagia in head and neck cancer patients treated with radiotherapy. Furthermore, we wanted to compare both patient- and physician-scored dysphagia with dysphagia evaluated on swallowing videofluoroscopies. Sixty-three patients from two different centers treated with radiotherapy for head and neck cancer were evaluated in the current study. Swallowing videofluoroscopies at baseline, 6, and 12 months following radiotherapy were evaluated by 2 observers using the Penetration Aspiration Scale (PAS) and Swallowing Performance Status Scale (SPS) and correlated with patient and physician scored dysphagia. We observed a significant association between physician and patient scored dysphagia (p < 0.01), pre-treatment and post-treatment. Furthermore, the risk of observing dysphagia on videofluoroscopies increased significantly with increasing scores of both physician as well as patient scored dysphagia, and this at all assessed time-points. Patient-scored dysphagia correlates better with dysphagia evaluated by the PAS. Physician-scored dysphagia, however, correlates better with dysphagia as evaluated using the SPS. Both physician- and patient-scored dysphagia correlate well with dysphagia evaluated on videofluoroscopies. Since patient-scored dysphagia correlates better with PAS and changes in the PAS score, and physician-scored dysphagia correlates better with SPS, we advocate to use both patient- and physician-scored dysphagia in future trials.
- 1 December 2017
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 90 (1080) , 20170596
Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?
Objective:The purpose of this study is to see whether sparing the superficial contralateral parotid lobe can help limiting xerostomia following radiotherapy for head and neck cancer.Methods:88 patients that were included in two prospective randomized studies were analysed in the current study. Using the dosimetry of both the parotid glands, we divided our patients in four groups. Group 1 includes patients where we were able to reduce the radiation dose below the threshold in order to spare both the ipsilateral and contralateral parotid glands, Group 2 consists of patients where only the contralateral parotid gland could be spared. Group 3 consists of patients where only the contralateral superficial parotid lobe could be spared, while in Group 4 not even the contralateral superficial lobe could be spared.Results:When we compared Group 1 and Group 2, we did not observe a significant difference between both groups in terms of xerostomia scores at 6 or 12 months. When we compared these groups with Group 3, w...
- 1 December 2017
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 90 (1080) , 20170596
Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?
Objective:The purpose of this study is to see whether sparing the superficial contralateral parotid lobe can help limiting xerostomia following radiotherapy for head and neck cancer.Methods:88 patients that were included in two prospective randomized studies were analysed in the current study. Using the dosimetry of both the parotid glands, we divided our patients in four groups. Group 1 includes patients where we were able to reduce the radiation dose below the threshold in order to spare both the ipsilateral and contralateral parotid glands, Group 2 consists of patients where only the contralateral parotid gland could be spared. Group 3 consists of patients where only the contralateral superficial parotid lobe could be spared, while in Group 4 not even the contralateral superficial lobe could be spared.Results:When we compared Group 1 and Group 2, we did not observe a significant difference between both groups in terms of xerostomia scores at 6 or 12 months. When we compared these groups with Group 3, w...
- 1 December 2017
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1083) , 20170714
Does the total dysphagia risk score correlate with swallowing function examined by videofluoroscopy?
Objective: The purpose of this study was to correlate the total dysphagia risk score (TDRS) with swallowing function as measured by videofluoroscopy of swallowing using the swallowing performance scale (SPS) and the penetration aspiration scale (PAS). Methods: 63 patients from two different centres treated with radiotherapy for head and neck cancer were evaluated in the current study. Swallowing videofluoroscopies at baseline, 6 and 12 months following radiotherapy were evaluated by two observers. The TDRS of all patients was calculated and correlated with the consensus PAS and SPS scores of the two observers. Results: Regarding the PAS scale, we did not observe a significant correlation with the TDRS. Regarding SPS, we found a significant correlation at 6 months (p = 0.01) and a borderline significant correlation at 12 months (p = 0.05). We observed statistically lower SPS scores for patients in the intermediate-risk category when compared to the high-risk category. When we compared low v s high TDRS risk patients, we did not observe a significant difference regarding SPS scores. When comparing low- vs intermediate-risk patients, we observed higher SPS scores in the low-risk group (p = 0.01). When the low- and intermediate-risk patients were grouped together, we observed less swallowing problems as measured by SPS in the low and intermediate group when compared to the high-risk group (p = 0.05) at 6 months. Conclusion: Patients with high-risk TDRS scores have higher SPS scores when compared to the intermediate group and the intermediate- and low-risk group together. However, low-risk patients in our patient cohort could not be distinguished from high or intermediate-risk patients. Advances in knowledge: TDRS was never correlated with videofluoroscopies in past studies. The hypothesis of this paper was to see if the TDRS could guide us to see which patients are at risk for high scores on SPS and PAS and might need a videofluoroscopic examination in the follow up. Given the poor correlations in our study, however, we cannot recommend the use of the TDRS to select patients who might benefit from the additional information provided by videofluoroscopies.
- 1 December 2017
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1083) , 20170714
Does the total dysphagia risk score correlate with swallowing function examined by videofluoroscopy?
Objective: The purpose of this study was to correlate the total dysphagia risk score (TDRS) with swallowing function as measured by videofluoroscopy of swallowing using the swallowing performance scale (SPS) and the penetration aspiration scale (PAS). Methods: 63 patients from two different centres treated with radiotherapy for head and neck cancer were evaluated in the current study. Swallowing videofluoroscopies at baseline, 6 and 12 months following radiotherapy were evaluated by two observers. The TDRS of all patients was calculated and correlated with the consensus PAS and SPS scores of the two observers. Results: Regarding the PAS scale, we did not observe a significant correlation with the TDRS. Regarding SPS, we found a significant correlation at 6 months (p = 0.01) and a borderline significant correlation at 12 months (p = 0.05). We observed statistically lower SPS scores for patients in the intermediate-risk category when compared to the high-risk category. When we compared low v s high TDRS risk patients, we did not observe a significant difference regarding SPS scores. When comparing low- vs intermediate-risk patients, we observed higher SPS scores in the low-risk group (p = 0.01). When the low- and intermediate-risk patients were grouped together, we observed less swallowing problems as measured by SPS in the low and intermediate group when compared to the high-risk group (p = 0.05) at 6 months. Conclusion: Patients with high-risk TDRS scores have higher SPS scores when compared to the intermediate group and the intermediate- and low-risk group together. However, low-risk patients in our patient cohort could not be distinguished from high or intermediate-risk patients. Advances in knowledge: TDRS was never correlated with videofluoroscopies in past studies. The hypothesis of this paper was to see if the TDRS could guide us to see which patients are at risk for high scores on SPS and PAS and might need a videofluoroscopic examination in the follow up. Given the poor correlations in our study, however, we cannot recommend the use of the TDRS to select patients who might benefit from the additional information provided by videofluoroscopies.
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 24-25
OC-045: Recurrence patterns after 40 Gy to the elective treated neck in head and neck cancer.
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 24-25
OC-045: Recurrence patterns after 40 Gy to the elective treated neck in head and neck cancer.
- Open Access
- 1 April 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115, S203
PD-0418: The use of diffusion weighted MRI in the prediction of volumetric changes during radiotherapy
- 1 April 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115, S203
Open AccessPD-0418: The use of diffusion weighted MRI in the prediction of volumetric changes during radiotherapy
- 1 February 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114, 22-23
PD-037: Prospective randomized adaptive dose-de-escalation-trial for the elective neck: acute toxicity and control
- 1 February 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114, 22-23
PD-037: Prospective randomized adaptive dose-de-escalation-trial for the elective neck: acute toxicity and control
- 1 February 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114, 48
PO-094: Can the mean dose delivered to the superficial parotid lobe predict xerostomia following RT in HNC?
- 1 February 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114, 48
PO-094: Can the mean dose delivered to the superficial parotid lobe predict xerostomia following RT in HNC?
- 1 February 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S9
PD-024: The use of Sequential Diffusion Weighted MRI in the Early Prediction of Volumetric Changes During Radiotherapy
- 1 February 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S9
PD-024: The use of Sequential Diffusion Weighted MRI in the Early Prediction of Volumetric Changes During Radiotherapy
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S456
EP-1185 THE EFFECT OF IMRT ON OUTCOME AND TOXICITY COMPARED TO 3DCRT. A MONO-CENTRIC, RETROSPECTIVE ANALYSIS
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S456
EP-1185 THE EFFECT OF IMRT ON OUTCOME AND TOXICITY COMPARED TO 3DCRT. A MONO-CENTRIC, RETROSPECTIVE ANALYSIS